logo
Cipla Health Introduces Nicotex Begin, a First-of-Its-Kind App for Smoking Cessation

Cipla Health Introduces Nicotex Begin, a First-of-Its-Kind App for Smoking Cessation

PRNewswire
Mumbai (Maharashtra) [India], May 15: In an effort to help smokers in their journey to quit smoking Nicotex, the market leader in smoking cessation has launched Nicotex Begin, a smoking cessation program delivered via a mobile app. Coming from the house of Cipla Health Limited, this first-of-its-kind platform is not just an app, it's a comprehensive, science-backed approach to quitting smoking that promises to increase the chances of quitting smoking by 5 times.
* 5 times more effective, science-backed way to quit smoking
Nicotex Begin provides a 12-Week Personalised Smoking Cessation Program which is a step-by-step, guided journey to quitting smoking combining behavioural therapy with WHO-recommended Nicotine Replacement Therapy (NRT) protocols. With this combination therapy, Nicotex Begin offers a comprehensive 360-degree support ecosystem that addresses the physical and psychological challenges of smoking cessation.
Commenting on the launch, Mr. Shivam Puri, MD & CEO, Cipla Health Limited, said, "At Cipla Health, we understand that quitting smoking is more than just a decision, it's a life-changing journey. That's why we've poured our energy into creating Nicotex Begin, a truly innovative solution designed to make the process easier, more structured, accessible, and far more effective. With our research showing a 5X higher chance of success, this is not just another product; it's a game-changer. It's a reflection of our relentless drive to not only improve wellness but also empower individuals to take control of their health and transform their lives. We're here to support people on this journey, every step of the way"
With its intuitive design and user interface, it ensures an engaging and stress-free experience for the users. Some other key features include Nicotine Replacement Therapy (NRT) integration with gums, patches, and lozenges to ease nicotine cravings, along with expert-led weekly counselling sessions, with additional sessions available as needed. Users can choose from two package options priced at Rs4,000 and Rs6,000 with the first session offered free.
The app also provides reading materials and videos to keep users motivated, tracks quitting progress through interactive prompts and data insights, and includes a daily health diary for users to log progress and keep counsellors informed. It proactively addresses potential relapse triggers, allowing experts to guide users back to week one or recommend medical consultation when necessary, ensuring a comprehensive and supportive quit-smoking journey.
It is available for download on Android and soon to be launched on iOS devices.
About Cipla Health Limited:
Cipla Health Limited, the fast-moving wellness goods (FMWG) arm of Cipla, was incorporated in 2015 with a vision to spearhead the wellness wave in India. Cipla Health has delivered rapid growth and today plays across a diverse portfolio of 20 brands with most key brands being No. 1 or No. 2 in their respective categories. The portfolio includes products in Pain Care (Omnigel), Smoking Cessation (Nicotex), Oral Rehydration Solutions (Prolyte), Medicated Ointments (Cipladine), Cough & Cold (Cofsils and Naselin), Multi Vitamins (Maxirich), Weight Gain (Endura Mass) and Personal Care (Rivela Dermascience, Cetafresh, Tugain Essentials).

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The silent impact: How COVID-19 affected mental health globally
The silent impact: How COVID-19 affected mental health globally

Time of India

time4 hours ago

  • Time of India

The silent impact: How COVID-19 affected mental health globally

When the pandemic hit, the world focused on physical health; flattening the curve, increasing ICU beds, securing vaccines. But while the virus attacked lungs and immunity, it also quietly infiltrated our minds. The psychological toll of COVID-19 has been immense, yet much of it remains unseen, unspoken, and under-addressed. Each nation experienced its own kind of lockdowns, losses, and uncertainty. But across continents, there was one common thread: a silent mental health crisis playing itself out behind closed doors. The pressures of solitude, pain of loss, economic uncertainty, and fear of the unknown were a recipe for emotional stress. In countries like India, where extended family and social gatherings form the fabric of daily life, sudden isolation led to deep emotional disconnection. For many living in multi-generational homes, the fear of infecting vulnerable elders caused lingering anxiety. Elsewhere, in cities across Europe or North America, living alone became a double-edged sword, offering safety from the virus but amplifying loneliness. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy Durable Perforated Stainless Steel Sheets Online – Trusted Suppliers Stainless Steel Sheets | Search ADS Search Now Undo Anxiety, depression, insomnia, and burnout surged quietly, globally, and persistently. A 2022 WHO report estimated that the global prevalence of anxiety and depression increased by over 25% during the pandemic's first year alone. That number only begins to scratch the surface. Many who needed help didn't seek it. Some didn't recognize what they were feeling. Others feared the stigma. Mental health was tested not just by the virus, but by the silence around it. People grieved loved ones they couldn't say goodbye to, lost jobs they built their lives around, missed milestones they'd dreamed of. The parents overnight turned into teachers. Healthcare professionals strained themselves to the limit. Students lost the precious years of social development. The record continues. And yet, amid all this, we would constantly remind ourselves to be grateful. Grateful we lived. Grateful others were worse off. But gratitude and sorrow don't have to be mutually exclusive. You can be thankful and still wounded. That's what makes this emotional damage so confusing. For many, the pandemic didn't cause mental health struggles it magnified what was already there. Pre-existing anxiety worsened. Past trauma resurfaced. Coping mechanisms, like alcohol or overworking, quietly spiraled into addiction. Even those who appeared fine on the outside were often managing an invisible storm within. One of the hardest-hit groups? The youth. Teens and young adults who are already navigating identity, relationships, and career pressure, were suddenly cut off from the very social systems that helped them grow. Online classes, canceled exams, and uncertainty about the future created a unique kind of emotional whiplash. In India, mental health services were overwhelmed, especially in urban centers. But rural areas, where awareness and access were already limited, faced an even greater challenge. The digital divide became not just an educational issue, but a mental health barrier too. Here's how to address these things: First, we must acknowledge that healing from the pandemic isn't just about physical recovery but it's also emotional. We need global and local mental health systems that are responsive, affordable, and stigma-free. Governments, employers, schools, and families all have a role to play. Second, we must normalize asking for help. Therapy isn't a sign of weakness. It is a step toward understanding. Whether you're dealing with anxiety, fatigue, or just feeling 'off,' it matters. You matter. This approach goes beyond diagnosis we create compassionate, culturally aware support that helps people find their footing again. The pandemic may have been global, but healing starts one mind at a time. Whether you're still carrying the weight of those years or just beginning to unpack them, know this: you're not alone, and recovery is possible. (Dr. Tonmoy Sharma, Psychiatrist Founder and CEO, Merlin Health) One step to a healthier you—join Times Health+ Yoga and feel the change

Government plans to wind down National Polio Surveillance Network centres in India
Government plans to wind down National Polio Surveillance Network centres in India

The Hindu

time8 hours ago

  • The Hindu

Government plans to wind down National Polio Surveillance Network centres in India

The government has proposed to wind down, in phases, the World Health Organization (WHO)-established National Polio Surveillance Network (NPSN), currently a countrywide network of over 200 units. Experts in the field have commented that the move would be premature and ill-advised at this stage, with India's neighbouring countries still harbouring cases of polio. Staff at the NPSN centres have received a communication from the WHO's representative in India, Roderico H. Ofrin, advising them of an upcoming transition initiated by the government. The transition involves a gradual drawdown of the NPSN units each year — from approximately 280 units in 2024-25 down to 190 in 2025-26, and further to 140 in 2026-27. This is also linked with a corresponding reduction in financial support from the government, according to the communique. The process of transition will begin in June. 'We are not disbanding teams overnight or winding down the network haphazardly; rather, specific units will phase out at set intervals as government systems ramp up and absorb these functions,' Dr. Ofrin said. This will help us ensure that, at any given time, critical surveillance activities continue with minimal or no gaps, he said. While he assured the staff of the NPSN that this would help retain critical surveillance activities, at some point, polio surveillance would be subsumed within the Integrated Diseases Surveillance Programme. But the proposed winding down of a key unit, at a time when global resurgence of polio has been reported, has not gone down well, with either staffers or public health experts. India was declared polio-free in 2014, after three years of no case caused by wild polio virus transmission. The gains came after a full-frontal attack launched on polio, through years of coordinated work and oral polio immunisation campaigns, with a number of organisations collaborating. Jacob John, prominent virologist and vaccine expert, who has been actively involved in polio eradication efforts, including as a member on the National Technical Advisory Group on Immunisation, said he was 'horrified' by the move. 'The world has lots of polio still. It is way too early to upset our current 'steady state',' he added. He pointed out that Afghanistan and Pakistan continued to have polio cases, and that it is too close for comfort, also pointing to the danger of vaccine-derived polio virus. 'For every type 1 wild virus polio in Pakistan, there are about 10-12 circulating vaccine-derived poliovirus polio cases, mostly type 2, globally. After April 2016, we have not immunised children against type 2. In case vaccine derived polio virus is imported into India, widespread transmission and polio cases by the dozen are expected,' Dr. John said. A long-time campaigner for injectable polio vaccines (IPVs), Dr. John suggests that India should first replace oral polio vaccine (OPV) with IPV. After one year, all OPV can be withdrawn. Then, one year later, we can look at dismounting the watch. 'If surveillance is diluted now, we become sitting ducks for the resurgence of polio due to circulating VDPV, type 2 most likely, and type 1 less likely,' Dr. John said. Dr. Ofrin's letter also touches upon job security for existing staff, but the polio surveillance medical officers in the country under the Special Services Agreement, said it's not at all reassuring. 'Each centre has at least four employees. Imagine the number of people who won't have a job,' one doctor said, speaking on condition of anonymity. He also said that, since 2014, the NPSN had been functioning as a unit of the Central government, which expanded the role of the staff to conduct surveillance for measles and rubella, DPT (diphtheria, pertussis or whooping cough, and tetanus), child vaccination, and training the health workforce every time a new vaccine was introduced. He pointed out that there seemed to be no rationale in shutting down these particular centres. 'Vaccine-preventable diseases are a critical area; the country's progress should not be compromised at this stage,' he said.

Study finds critical medicine shortages for diabetes, hypertension at rural health facilities
Study finds critical medicine shortages for diabetes, hypertension at rural health facilities

Time of India

time15 hours ago

  • Time of India

Study finds critical medicine shortages for diabetes, hypertension at rural health facilities

New Delhi: A joint survey conducted by the ICMR and the WHO, along with other institutes, has revealed critical medicine shortages for managing diabetes and hypertension at rural health facilities, from sub-centres to sub-district hospitals, across 19 districts in seven states. The study has also found a shortage of specialists at the community health centre (CHC) level and these findings are similar to the rural health statistics report of 2020-21, indicating a shortfall of physicians (82.2 per cent) and surgeons (83.2.9 per cent) at the CHC-level. The study findings, published in the "Indian Journal of Medical Research (IJMR)" suggest that among public health facilities, PHCs, district hospitals and government medical colleges in India are better prepared to manage services for diabetes and hypertension. Across all the facilities, the domain score for equipment was the highest and for medicines, it was the lowest. However, the availability of all medicines was better at tertiary-care facilities (public and private) compared to other levels of public health facilities. A cross-sectional survey of the health facilities was conducted in 19 districts of seven states, which included an assessment of both public and private health facilities. The Indian Public Health Standards and other relevant guidelines were used for the assessment. The service domain score for four domains: equipment, medicine, diagnostics capacity and staff, including the availability of guidelines, and the overall readiness score was calculated following the service availability and readiness assessment manual of the World Health Organisation (WHO). In two phases of data collection, 415 health facilities were covered, of which 75.7 per cent were public and 24 per cent were private. The number of facilities assessed varied across the states. More than half (57.6 per cent) of the health facilities assessed were primary level (33.5 per cent), followed by secondary (33.5 per cent) and tertiary (10 per cent) facilities. More than half (56.3 per cent) of the health facilities were in rural areas. More than three-fourths of all public and private health facilities reported being involved in the follow up of diabetes and hypertension patients. The most common mode of follow ups across all facilities was self-reporting by patients (61.4 to 100 per cent), except for in SCs (29.5 per cent). At SCs, the most common mode of follow up was home visits by health workers (60.4 per cent). The availability of out-referral and in-referral registers across all levels and types of facilities was between 25 and 53.8 per cent and 14 and 61.5 per cent, respectively. "Most public health facilities (from SCs to SDHs) reported stockouts of essential medicines for managing diabetes and hypertension. Out of the 105 SCs assessed, nearly one-third (37/105; 35.2 per cent) reported stockouts of tablet metformin, and nearly less than half (47/105; 44.8 per cent) reported stockouts of tablet amlodipine," the study stated. The median duration of the stockouts for the medicines ranged from one to seven months. The SCs reported more stockouts of essential anti-diabetes and anti-hypertensive medicines compared to any other types of facilities. These medicines were better available at government medical colleges compared to any other levels of public health facilities. The medicine availability score at the primary health centres (PHCs) was just 66 per cent, far below the ideal threshold of 100 per cent. "Our findings suggest that among public health facilities, PHCs, district hospitals and government medical colleges in India are better prepared to manage services for diabetes and hypertension. Across all the facilities, the domain score for equipment was the highest, and for medicines, it was the lowest," the study said. It mentioned the ICMR-India Diabetes Study (ICMR-INDIAB) report's evidence of an NCD epidemic spreading to rural areas in India, in addition to the urban areas, due to changes in the lifestyle. Therefore, improving the preparedness of the SCs will further enhance the primary-care services closer to the homes of people, it stressed. The government has already accelerated its efforts towards strengthening Comprehensive Primary Health Care (CPHC) for achieving Universal Health Care by committing resources and efforts through its flagship Ayushman Bharat Health and Wellness Centres (AB-HWCs). These were recently renamed as Ayushman Arogya Mandirs. "During our assessment, the majority of PHCs (64 per cent) were converted to Health and Wellness Centres (HWCs). This indicates that PHC-HWCs were better prepared to provide comprehensive services compared to SCs, as nearly half of them (52.3 per cent) were transformed into HWCs. However, we found that diagnostic services were less available at district hospitals, indicating that secondary higher-level public health facilities were not fully prepared to manage complications of these two conditions," the study pointed out. Efforts to strengthen diagnostic services are essential for the continuum of care, as there will be in-referrals of patients from peripheral public health facilities to DHs, it said. Lessons from the India Hypertension Control Initiatives (IHCI) project can be adapted to ensure a reliable drug supply and accurate information systems in primary health care facilities, it added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store